Parallelization of large-scale drug-protein binding experiments

被引:0
|
作者
Michail, Dirnitrios [1 ]
Makris, Antonios [1 ]
Varlamis, Iraklis [1 ]
Sawyer, Mark [2 ]
机构
[1] Harokopio Univ Athens, Dept Informat & Telemat, Athens, Greece
[2] Univ Edinburgh, EPCC, Edinburgh, Midlothian, Scotland
来源
FUTURE GENERATION COMPUTER SYSTEMS-THE INTERNATIONAL JOURNAL OF ESCIENCE | 2019年 / 97卷
基金
英国工程与自然科学研究理事会;
关键词
Molecular dynamics simulation; Drug-protein structural similarity; High performance computing; ALGORITHM; SITES; ALIGNMENT; GEOMETRY;
D O I
10.1016/j.future.2019.02.065
中图分类号
TP301 [理论、方法];
学科分类号
081202 ;
摘要
The pharmaceutical industry invests billions of dollars on a yearly basis for new drug research. Part of this research is focused on the repositioning of established drugs to new disease indications and is based on "drug promiscuity", or in plain words, on the ability of certain drugs to bind multiple proteins. The increased cost of wet-lab experiments makes the in-silico alternatives a promising solution. In order to find similar protein targets for an existing drug, it is necessary to analyse the protein and drug structures and find potential similarities. The latter is a highly demanding in computational resources task. However, algorithmic advances in conjunction with increased computational resources can leverage this task and increase the success rate of drug discovery with significantly smaller cost. The current work proposes several algorithms that implement the protein similarity task in a parallel high-performance computing environment, solve several load imbalance and memory management issues and take maximum advantage of the available resources. The proposed optimizations achieve better memory and CPU balancing and faster execution times. Several parts of the previously linear processing pipeline, which used different software packages, have been re-engineered in order to improve process parallelization. Experimental results, on a high-performance computing environment with up to 1024 cores and 2048GB of memory, demonstrate the effectiveness of our approach, which scales well to large amounts of protein pairs. (C) 2019 Elsevier B.V. All rights reserved.
引用
收藏
页码:492 / 502
页数:11
相关论文
共 50 条
  • [21] Adverse Drug Reaction Prediction Using Scores Produced by Large-Scale Drug-Protein Target Docking on High-Performance Computing Machines
    LaBute, Montiago X.
    Zhang, Xiaohua
    Lenderman, Jason
    Bennion, Brian J.
    Wong, Sergio E.
    Lightstone, Felice C.
    PLOS ONE, 2014, 9 (09):
  • [22] DRUG-PROTEIN INTERACTION - PLASMA-PROTEIN BINDING OF FUROCOUMARINS
    VERONESE, FM
    BEVILACQUA, R
    SCHIAVON, O
    RODIGHIERO, G
    FARMACO-EDIZIONE SCIENTIFICA, 1979, 34 (08): : 716 - 725
  • [23] COMPUTER-ANALYSIS OF DRUG-PROTEIN BINDING DATA
    FLETCHER, JE
    ASHBROOK, JD
    SPECTOR, AA
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1973, 226 (NOV26) : 69 - 81
  • [24] Multiscale simulation approaches to modeling drug-protein binding
    Jagger, Benjamin R.
    Kochanek, Sarah E.
    Haldar, Susanta
    Amaro, Rommie E.
    Mulholland, Adrian J.
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2020, 61 : 213 - 221
  • [25] Aspects of Drug-Protein Binding and Methods of Analyzing the Phenomenon
    Wanat, Karolina
    Brzezinska, Elzbieta
    Sobanska, Anna W.
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (25) : 2974 - 2985
  • [26] DRUG-PROTEIN BINDING METHODS OF ANALYSIS OF EXPERIMENTAL RESULTS
    MONOT, C
    MARTIN, J
    NETTER, P
    STALARS, MC
    ROYER, RJ
    GAUCHER, A
    ANNALES DE BIOLOGIE CLINIQUE, 1982, 40 (04) : 501 - 501
  • [27] CLINICAL IMPLICATIONS OF DRUG-PROTEIN BINDING - PANEL DISCUSSION
    SHAND, D
    WOOSLEY, R
    BOWERS, W
    OELLERICH, M
    CLINICAL PHARMACOKINETICS, 1984, 9 : 102 - 104
  • [28] DRUG-PROTEIN BINDING INTERFERENCES CAUSED BY THE PLASTICIZER TBEP
    DEVINE, JE
    CLINICAL CHEMISTRY, 1983, 29 (06) : 1198 - 1198
  • [29] DRUG-PROTEIN BINDING INTERFERENCES CAUSED BY THE PLASTICIZER TBEP
    DEVINE, JE
    CLINICAL BIOCHEMISTRY, 1984, 17 (06) : 345 - 347
  • [30] Understanding drug-protein binding and ADME studies for DMPK
    Xie, Vivian
    BIOANALYSIS, 2022, 14 (13) : 919 - 921